BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21147279)

  • 1. Care for patients with ultra-rare disorders.
    Hennekam RC
    Eur J Med Genet; 2011; 54(3):220-4. PubMed ID: 21147279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rare diseases in pulmonary medicine and its challenges].
    Wencker M; Teschler H; Vogelmeier C; Koczulla R
    Pneumologie; 2012 Jul; 66(7):437-41. PubMed ID: 22692970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimising treatment for people with rare diseases].
    Lund AM; Skovby F
    Ugeskr Laeger; 2006 Apr; 168(15):1547-50. PubMed ID: 16640978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Prader-Willi Syndrome Clinical Research Database: an aid in the investigation of a rare genetically determined neurodevelopmental disorder.
    Holland A; Whittington J; Cohen O; Curfs L; Delahaye F; Dudley O; Horsthemke B; Lindgren AC; Nourissier C; Sharma N; Vogels A
    J Intellect Disabil Res; 2009 Jun; 53(6):538-47. PubMed ID: 19457156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Needs in rare diseases during paediatric age].
    Gaite L; García Fuentes M; González Lamuño D; Alvarez J
    An Sist Sanit Navar; 2008; 31 Suppl 2():165-75. PubMed ID: 18953379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care physicians in Israel: self-perception of their role in the healthcare system and policy makers' and patients' perception of them as gatekeepers.
    Tabenkin H; Gross R; Greenberg SB; Steinmetz D; Elhayany A
    Isr Med Assoc J; 2001 Dec; 3(12):893-7. PubMed ID: 11794909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Orphanet and the Dutch Steering Committee Orphan Drugs. A European and Dutch databank of information on rare diseases].
    Liem SL
    Ned Tijdschr Tandheelkd; 2008 Nov; 115(11):621-3. PubMed ID: 19058507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A framework to evaluate the effects of small area variations in healthcare infrastructure on diagnostics and patient outcomes of rare diseases based on administrative data.
    Stargardt T; Schreyögg J
    Health Policy; 2012 May; 105(2-3):110-8. PubMed ID: 22342575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Call for a national plan for rare diseases.
    Jaffe A; Zurynski Y; Beville L; Elliott E
    J Paediatr Child Health; 2010 Jan; 46(1-2):2-4. PubMed ID: 19943870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare diseases and orphan drugs.
    Taruscio D; Capozzoli F; Frank C
    Ann Ist Super Sanita; 2011; 47(1):83-93. PubMed ID: 21430345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health research on rare diseases.
    Alonso V; Villaverde-Hueso A; Hens M; Morales-Piga A; Abaitua I; Posada de la Paz M
    Georgian Med News; 2011 Apr; (193):11-6. PubMed ID: 21617266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for rare diseases: mixed assessment in Europe.
    Prescrire Int; 2007 Feb; 16(87):36-42. PubMed ID: 17323539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing drugs for rare genetic diseases: trends and insights.
    Zitter M
    Manag Care; 2005 Feb; 14(2):52-4, 57-60, 63-4; quiz 66-7. PubMed ID: 15782848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research performance of centers of expertise for rare diseases--the influence of network integration, internal resource access and operational experience.
    Hannemann-Weber H; Kessel M; Schultz C
    Health Policy; 2012 May; 105(2-3):138-45. PubMed ID: 22401748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy.
    Liu BC; He L; He G; He Y
    J Public Health Policy; 2010 Dec; 31(4):407-20; discussion 420-1. PubMed ID: 21119648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building treasures for rare disorders.
    Baas M; Huisman S; van Heukelingen J; Koekkoek G; Laan HW; Hennekam RC
    Eur J Med Genet; 2015 Jan; 58(1):11-3. PubMed ID: 25449139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor Group.
    Brecht IB; Graf N; Schweinitz Dv; Frühwald MC; Bielack SS; Schneider DT
    Klin Padiatr; 2009; 221(3):181-5. PubMed ID: 19437371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assuring access to dental care for low-income families in North Carolina. The NC Institute of Medicine Task Force Study.
    Silberman P; Wicker DA; Smith SH; DeFriese GH
    N C Med J; 2000; 61(2):95-8. PubMed ID: 10737031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.